Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Russian Academy of Sciences cyclin-dependent kinase 2 (CDK2) compound 3d
- Development stage
- Preclinical
- Lead developer
- Russian Academy of Sciences
01
Overview
Russian Academy of Sciences cyclin-dependent kinase 2 (CDK2) compound 3d: sourced facts only. name: "Additionally, compound 3d exhibited inhibitory activity against cyclin-dependent kinase 2 (CDK2)." [PMID:42035247]; target: "Additionally, compound 3d exhibited inhibitory activity against cyclin-dependent kinase 2 (CDK2)." [PMID:42035247]; developer: "Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, Kazan, Russian Federation." [PMID:42035247]; stage: "Lead compounds 3g and 3d demonstrated selectivity toward M-HeLa cells compared to Chang liver cells, suggesting their potential therapeutic value." [PMID:42035247]
02
Targets
CDK2 (Cyclin-dependent kinase 2)
Beyond the preview
Go deeper on Russian Academy of Sciences cyclin-dependent kinase 2 (CDK2) compound 3d.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Russian Academy of Sciences cyclin-dependent kinase 2 (CDK2) compound 3d.